创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Features of the preclinical evaluation platform for tumor vaccines

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-11 15:22
  • Views:

(Summary description)With the continuous advancement of cancer treatment, tumor vaccines, as an emerging means of immunotherapy, have received widespread attention. However, the development and evaluation of tumor vaccines require highly specialized platforms to ensure the accuracy and reliability of their experimental data. The InnoModels Biotechnology tumor vaccine preclinical evaluation platform was born to meet this need, and it provides powerful support and tools for tumor vaccine development with its unique features.

InnoModels Biotechnology: Features of the preclinical evaluation platform for tumor vaccines

(Summary description)With the continuous advancement of cancer treatment, tumor vaccines, as an emerging means of immunotherapy, have received widespread attention. However, the development and evaluation of tumor vaccines require highly specialized platforms to ensure the accuracy and reliability of their experimental data. The InnoModels Biotechnology tumor vaccine preclinical evaluation platform was born to meet this need, and it provides powerful support and tools for tumor vaccine development with its unique features.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-11 15:22
  • Views:
Information

With the continuous advancement of cancer treatment, tumor vaccines, as an emerging means of immunotherapy, have received widespread attention. However, the development and evaluation of tumor vaccines require highly specialized platforms to ensure the accuracy and reliability of their experimental data. The InnoModels Biotechnology tumor vaccine preclinical evaluation platform was born to meet this need, and it provides powerful support and tools for tumor vaccine development with its unique features.
1、Comprehensive construction of the immune system
The preclinical evaluation platform for tumor vaccines of InnoModels Biotechnology comprehensively constructs lymphocytes and myeloid cells to ensure the effective presentation of antigens in the body. This comprehensive construction of the immune system enables the platform to more realistically simulate the immune response in the human body, providing more accurate and reliable experimental data for the evaluation of tumor vaccines.
2. Realistic and effective evaluation environment
The platform provides a real and effective evaluation environment for tumor vaccines by highly simulating the response of the human immune system. In this environment, researchers can comprehensively evaluate the effect of tumor vaccines in vivo, including their induced immune response, killing effect on tumor cells, etc., thus providing an important basis for the clinical application of tumor vaccines.

 


3. Highly customizable experimental design
InnoModels' tumor vaccine preclinical evaluation platform supports highly customizable experimental design to meet the specific needs of different research teams for tumor vaccine evaluation. Researchers can flexibly adjust the experimental conditions, cell types and vaccination methods according to their own research objectives and protocols to obtain more accurate and personalized experimental results.
4、Advanced experimental technology and equipment
The platform adopts advanced experimental technology and equipment to ensure the accuracy and reliability of the experimental process. For example, the platform adopts flow cytometry, real-time fluorescence quantitative PCR and other advanced technologies to accurately detect and quantitatively analyze tumor cells, immune cells and so on. These advanced equipments and technologies provide powerful technical support for researchers, making the experimental results more accurate and credible.
5、Professional technical support and service
InnoModels Biotechnology-Tumor Vaccine Preclinical Evaluation Platform provides professional technical support and services to provide researchers with all-round experimental guidance and assistance. Whether it is experimental design, experimental operation or data analysis, the platform can provide professional guidance and support to ensure that researchers can successfully complete the experiments and obtain accurate experimental results.
In conclusion, with its comprehensively constructed immune system, real and effective evaluation environment, highly customizable experimental design, advanced experimental technology and equipment, as well as professional technical support and services, InnoModels' tumor vaccine preclinical evaluation platform provides powerful support and tools for tumor vaccine R&D and evaluation. It is believed that with the help of the preclinical evaluation platform of tumor vaccines of InnoModels Biotechnology, the research and development and application of tumor vaccines will make greater breakthroughs and progress.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司